Summit Creek Advisors LLC Sells 36,654 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Summit Creek Advisors LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 6.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 530,460 shares of the company’s stock after selling 36,654 shares during the period. Option Care Health accounts for about 2.0% of Summit Creek Advisors LLC’s portfolio, making the stock its 26th biggest holding. Summit Creek Advisors LLC owned approximately 0.31% of Option Care Health worth $14,694,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in OPCH. Principal Securities Inc. purchased a new position in Option Care Health in the 4th quarter worth approximately $27,000. Parallel Advisors LLC lifted its holdings in shares of Option Care Health by 130.2% in the fourth quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after buying an additional 478 shares in the last quarter. TFO Wealth Partners LLC boosted its position in shares of Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after acquiring an additional 985 shares during the last quarter. Park Place Capital Corp boosted its position in shares of Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after acquiring an additional 372 shares during the last quarter. Finally, Blue Trust Inc. grew its stake in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

OPCH stock opened at $32.62 on Friday. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $35.24. The firm has a market capitalization of $5.67 billion, a P/E ratio of 21.46, a price-to-earnings-growth ratio of 2.43 and a beta of 1.29. The company has a fifty day simple moving average of $30.25 and a two-hundred day simple moving average of $30.53. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The firm had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. During the same quarter last year, the firm earned $0.63 EPS. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. Analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have commented on OPCH shares. Barrington Research boosted their price target on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. JMP Securities assumed coverage on Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 target price on the stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.